Scholar Award

Development and assessment of strategies to promote social integration into new communities

Social connections and social support networks are essential for physical and mental health. In fact, recent research suggests that how long people live is better predicted by the quality of their social relationships and how well they are integrated in their community, than it is by how much they smoke and drink, or whether they are obese. Loneliness, on the other hand, is linked to negative health outcomes including depression, poor sleep quality, more hospital and doctor visits, and compromised immune system functioning.

Primary Investigator: 
Award Type: 
Year: 
2017
Health Category: 

Cardiovascular genetics: Phenotypes, genotypes and cellular mechanisms

Cardiovascular disease (CVD) is the leading cause of death of Canadians, and is strongly influenced by genetic factors. Integrating basic biomedical research into how specific gene variants influence the function of cardiac cells, with clinical research of patients and families with early onset CVD, will lead to important advances in translating the results of genetics research to improved care for patients and families with CVD.

Primary Investigator: 
Award Type: 
Year: 
2017
Health Category: 

Advancing Healthcare Diagnostics for Neurodegenerative Disorders

Alzheimer’s disease causes progressive neurological decline and substantially decreases the quality of life of patients and their caregivers. In 2011, 747,000 Canadians had Alzheimer’s disease or another form of dementia. With a rapidly aging population, this figure is projected to rise to 1.4 million by 2040, costing $293 billion/year, thus representing an urgent and rapidly growing healthcare issue.

Primary Investigator: 
Award Type: 
Year: 
2016

CALOR: Cooling Autoinflammation with cLinically Oriented Research

MSFHR/Cassie and Friends Society for Children with Juvenile Arthritis and Other Rheumatic Diseases Scholar Award

Primary Investigator: 
Award Type: 
Year: 
2016

Transforming Urban Form for Mobility: Interventions to improve population health

Governments are making major investments in transit, cycling, and walking infrastructure to alleviate the pressures of traffic congestion and emissions. These changes may have lasting impacts on population health.

The aim of this five-year program is to generate new evidence on the impact of population health interventions on health and health equity along two lines: 
 

Primary Investigator: 
Award Type: 
Year: 
2016

Understanding and exploiting genome instability in cancer

Cancer is caused by specific DNA mutations that can arise spontaneously over time. Conditions that increase DNA damage or inhibit DNA repair can promote cancer. Genetic factors that affect a cells’ ability to protect and repair DNA promote cancer formation by causing so-called genome instability, defined as an increase in the frequency with which mutations are passed to daughter cells.

Primary Investigator: 
Award Type: 
Year: 
2016

Respiratory Evaluation Sciences Program: Innovations in analytic approaches to improve efficiency in respiratory care

Asthma and chronic obstructive pulmonary disease (COPD) are among the most prevalent chronic diseases in Canada. This research program aims to improve patient outcomes and the efficiency of health care delivery in chronic respiratory diseases like asthma and COPD. The outputs of this research program will help enable evidence-informed decision making at all levels of care.

Primary Investigator: 
Award Type: 
Year: 
2016

Personalized genomics for improving drug safety: From discovery to implementation.

Medications ideally improve patient health, occasionally with mild or moderate side effects. But sometimes patients have significant damaging responses to drugs, events called adverse drug reactions (ADRs). In Canada, there are 87,000 – 200,000 debilitating or life-threatening ADRs, which cause 3,600 – 10,000 deaths each year. The problem is worse in children, where ADRs are three times more life threatening than in adults.

Primary Investigator: 
Award Type: 
Year: 
2016

The development of novel blood protein biomarkers to enable precision care in cystic fibrosis

Cystic fibrosis is the most common fatal genetic disease, affecting one out of every 3,600 children born in Canada. In 2013 alone, Canadians with cystic fibrosis spent about 25,000 days in hospital, mainly due to pulmonary exacerbations, which cause respiratory distress due to excessive mucus production, infection, and inflammation in the lungs.

Primary Investigator: 
Award Type: 
Year: 
2016

Habitual Physical Activity as Stress Resiliency in Populations Experiencing High Adversity

In light of extensive research linking stress and disease, and the high rates of reported stress in Canadians, there is a need to identify what people can do to protect their health from the ill effects of stress.

Primary Investigator: 
Award Type: 
Year: 
2016

Responding to HIV and other blood-borne pathogens among people who use illicit drugs

The intertwined pandemics of addiction and HIV/AIDS remain a public health crisis. Among people who use drugs, a substantial number live with HIV/AIDS and many experience suboptimal treatment outcomes.

Primary Investigator: 
Award Type: 
Year: 
2016

A Research Program to Ensure the Effective Delivery of Substance Use Treatment Across Acute and Community Care Settings

Substance use disorders are a major contributor to preventable illness and death, including HIV and hepatitis C infection. An effective response to this public health crisis depends on using evidence-based practices in acute and community care settings (addiction health care) to understand factors that influence access to health services and people’s drug use.

This program examines health care and substance use through three interconnected lines of inquiry:

Primary Investigator: 
Award Type: 
Year: 
2016

A comparative and cross-jurisdictional research program on work and health

This project seeks to improve our means of developing social, economic, and workplace policies that improve worker health and reduce worker health inequalities. It builds on existing stakeholder collaborations and is structured around a series of comparative and cross-jurisdictional studies on occupational health and safety and workers’ compensation.

Primary Investigator: 
Award Type: 
Year: 
2016

Translational Proteomics and Systems Biology of Pediatric Malignancies

In Canada, cancer is the leading cause of disease-related death in children beyond the newborn period. Each year, more than 3,000 Canadian children, adolescents, and young adults are diagnosed with cancer. Childhood cancer survivors with secondary cancers in adulthood are the sixth most common form of adult cancer, and late effects of cancer treatment are estimated to cost $1 million per child over their lifetime.

Primary Investigator: 
Award Type: 
Year: 
2016

Pages

Subscribe to RSS - Scholar Award